Cargando…
Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
BACKGROUND: There are currently no standard diagnostic criteria for characterizing advanced Parkinson’s disease (APD) in clinical practice, a critical component in determining ongoing clinical care and therapeutic strategies, including transitioning to device-aided treatment. The goal of this analys...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444751/ https://www.ncbi.nlm.nih.gov/pubmed/30940119 http://dx.doi.org/10.1186/s12883-019-1276-8 |
_version_ | 1783408078323974144 |
---|---|
author | Fasano, Alfonso Fung, Victor S. C. Lopiano, Leonardo Elibol, Bulent Smolentseva, Irina G. Seppi, Klaus Takáts, Annamária Onuk, Koray Parra, Juan Carlos Bergmann, Lars Sail, Kavita Jalundhwala, Yash Pirtosek, Zvezdan |
author_facet | Fasano, Alfonso Fung, Victor S. C. Lopiano, Leonardo Elibol, Bulent Smolentseva, Irina G. Seppi, Klaus Takáts, Annamária Onuk, Koray Parra, Juan Carlos Bergmann, Lars Sail, Kavita Jalundhwala, Yash Pirtosek, Zvezdan |
author_sort | Fasano, Alfonso |
collection | PubMed |
description | BACKGROUND: There are currently no standard diagnostic criteria for characterizing advanced Parkinson’s disease (APD) in clinical practice, a critical component in determining ongoing clinical care and therapeutic strategies, including transitioning to device-aided treatment. The goal of this analysis was to determine the proportion of APD vs. non-advanced PD (non-APD) patients attending specialist PD clinics and to demonstrate the clinical burden of APD. METHODS: OBSERVE-PD, a cross-sectional, international, observational study, was conducted with 2615 PD patients at 128 movement disorder centers in 18 countries. Motor and non-motor symptoms, activities of daily living, and quality-of-life end points were assessed. The correlation between physician’s global assessment of advanced PD and the advanced PD criteria from a consensus of an international group of experts (Delphi criteria for APD) were evaluated. RESULTS: According to physician’s judgment, 51% of patients were considered to have APD. There was a moderate correlation between physician’s judgment and Delphi criteria for APD (K = 0.430; 95% CI 0.406–0.473). Activities of daily living, motor symptom severity, dyskinesia duration/disability, “Off” time duration, non-motor symptoms, and quality-of-life scores were worse among APD vs. non-APD patients (p < 0.0001 for all). APD patients (assessed by physicians) had higher disease burden by motor and non-motor symptoms compared with non-APD patients and a negative impact on activities of daily living and quality of life. CONCLUSIONS: These findings aid in identifying standard APD classification parameters for use in practicing physicians. Improvements in identification of APD patients may be particularly relevant for optimizing treatment strategies including transitioning to device-aided treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-019-1276-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6444751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64447512019-04-12 Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients Fasano, Alfonso Fung, Victor S. C. Lopiano, Leonardo Elibol, Bulent Smolentseva, Irina G. Seppi, Klaus Takáts, Annamária Onuk, Koray Parra, Juan Carlos Bergmann, Lars Sail, Kavita Jalundhwala, Yash Pirtosek, Zvezdan BMC Neurol Research Article BACKGROUND: There are currently no standard diagnostic criteria for characterizing advanced Parkinson’s disease (APD) in clinical practice, a critical component in determining ongoing clinical care and therapeutic strategies, including transitioning to device-aided treatment. The goal of this analysis was to determine the proportion of APD vs. non-advanced PD (non-APD) patients attending specialist PD clinics and to demonstrate the clinical burden of APD. METHODS: OBSERVE-PD, a cross-sectional, international, observational study, was conducted with 2615 PD patients at 128 movement disorder centers in 18 countries. Motor and non-motor symptoms, activities of daily living, and quality-of-life end points were assessed. The correlation between physician’s global assessment of advanced PD and the advanced PD criteria from a consensus of an international group of experts (Delphi criteria for APD) were evaluated. RESULTS: According to physician’s judgment, 51% of patients were considered to have APD. There was a moderate correlation between physician’s judgment and Delphi criteria for APD (K = 0.430; 95% CI 0.406–0.473). Activities of daily living, motor symptom severity, dyskinesia duration/disability, “Off” time duration, non-motor symptoms, and quality-of-life scores were worse among APD vs. non-APD patients (p < 0.0001 for all). APD patients (assessed by physicians) had higher disease burden by motor and non-motor symptoms compared with non-APD patients and a negative impact on activities of daily living and quality of life. CONCLUSIONS: These findings aid in identifying standard APD classification parameters for use in practicing physicians. Improvements in identification of APD patients may be particularly relevant for optimizing treatment strategies including transitioning to device-aided treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-019-1276-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-02 /pmc/articles/PMC6444751/ /pubmed/30940119 http://dx.doi.org/10.1186/s12883-019-1276-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Fasano, Alfonso Fung, Victor S. C. Lopiano, Leonardo Elibol, Bulent Smolentseva, Irina G. Seppi, Klaus Takáts, Annamária Onuk, Koray Parra, Juan Carlos Bergmann, Lars Sail, Kavita Jalundhwala, Yash Pirtosek, Zvezdan Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients |
title | Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients |
title_full | Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients |
title_fullStr | Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients |
title_full_unstemmed | Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients |
title_short | Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients |
title_sort | characterizing advanced parkinson’s disease: observe-pd observational study results of 2615 patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444751/ https://www.ncbi.nlm.nih.gov/pubmed/30940119 http://dx.doi.org/10.1186/s12883-019-1276-8 |
work_keys_str_mv | AT fasanoalfonso characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT fungvictorsc characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT lopianoleonardo characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT elibolbulent characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT smolentsevairinag characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT seppiklaus characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT takatsannamaria characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT onukkoray characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT parrajuancarlos characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT bergmannlars characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT sailkavita characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT jalundhwalayash characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients AT pirtosekzvezdan characterizingadvancedparkinsonsdiseaseobservepdobservationalstudyresultsof2615patients |